Evidence map›Paper›PMID 34345042›Full record

ReviewThe Journal of antibiotics2021

Splicing modulators: on the way from nature to clinic.

Tilman Schneider-Poetsch, Jagat Krishna Chhipi-Shrestha, Minoru Yoshida

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of antibiotics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. TheInternational journal of molecular sciences · 2025
    Review
  7. A Chemically Induced CRISPR/dCas13Journal of medicinal chemistry · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Covalent targeting of splicing in T cells.Cell chemical biology · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tilman Schneider-PoetschChemical Genomics Research Group, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan. tsp@riken.jp.
Jagat Krishna Chhipi-ShresthaChemical Genomics Research Group, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.
Minoru YoshidaChemical Genomics Research Group, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.ORCID http://orcid.org/0000-0002-4376-5674
RIKEN Center for Sustainable Resource Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the course of more than two decades, natural products isolated from various microorganisms and plants have built the foundation for chemical biology research into the mechanism of pre-mRNA splicing. Hand in hand with advances in scientific methodology small molecule splicing modulators have become powerful tools for investigating, not just the splicing mechanism, but also the cellular effect of altered mRNA processing. Based on thorough structure-activity studies, synthetic analogues have moved on from scientific tool compounds to experimental drugs. With current advances in drug discovery methodology and new means of attacking targets previously thought undruggable, we can expect further advances in both research and therapeutics based on small molecule splicing modulators.

Indexed as

Alternative SplicingAnimalsAntineoplastic AgentsBiological ProductsHumansAntineoplastic AgentsBiological Products

Identifiers

PMID34345042
PMCPMC8472923
OpenAlexW3187503891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.